HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells. (2014)

First Author: Stanton RJ
Attributed to:  Utilising proteomics to develop anti-HCMV immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chom.2014.07.005

PubMed Identifier: 25121749

Publication URI: http://europepmc.org/abstract/MED/25121749

Type: Journal Article/Review

Volume: 16

Parent Publication: Cell host & microbe

Issue: 2

ISSN: 1931-3128